The main policies of the reform of the drug production and circulation system: 1. Increase the adjustment of the drug production structure strictly, strictly enter the access conditions of drug production enterprises, control the capacity of new production and processing, and stop low -level repetitive construction. In the future, pharmaceutical manufacturers must gradually reach the “Quality Management Specifications for Drug Production Enterprises” (GMP). Encourage drug manufacturers to increase technology investment and develop new products and special products. 2. Accelerate the reform of the property rights system of pharmaceutical manufacturers and encourage various industries and various economic components to participate in various methods such as mergers, reorganization, and union. Actively cultivate and develop diversified investment entities, promote pharmaceutical distribution enterprises to enhance market competitiveness to improve the economic benefits of enterprises, in accordance with the principles of equality, mutual benefit and complementary advantages, use enterprises as the main body and capital as the link. Through the market, a group of group companies cross -regional, cross -industry, cross -ownership and multinational operations are formed. 3. Promote the reform of drug circulation order and advocate that pharmaceutical wholesale enterprises implement proxy distribution systems. Allows and encourages conditional wholesale enterprises to merge across regions or unite cities and county -level wholesale enterprises to reorganize the city and county -level wholesale enterprises into regional grassroots distribution centers to implement unified purchase, unified marketing strategies, unified accounting, and approval of zero integrity , Form a large -scale advantage operation and change the situation of decentralized operations within the enterprise. In order to reduce costs, improve benefits, and provide high -quality, convenient and fast services. Advocating pharmaceutical retail enterprises to implement chain operations. Under the principle of adhering to the “reasonable layout and facilitating the masses”, the implementation of the central city pharmaceutical retail enterprises to take a chain road and actively develop community pharmacies, and promote the centralization of pharmaceutical retail. Pharmaceutical retail chain enterprises implement six unifications of purchase, storage, transportation, price, corporate image, internal management and economic accounting to increase benefits, reduce costs, reduce prices, and benefit the country and the people. Implement bidding and procurement of drugs of medical institutions. In order to regulate the drug purchase and sales activities of medical institutions, increase the transparency of drug procurement, curb the inappropriate winds in the field of drug circulation, reduce the burden of social medical expenses, and ensure the smooth implementation of the basic medical insurance system of urban employees, and medical institutions in counties and counties above the counties And the drugs with a large number of clinical use of centralized bidding and procurement.
Legal basis: “The Law of the Chinese Medicine of the People’s Republic of China” The national medicines formulated, collected, storage, and initial processing of traditional Chinese pharmaceutical materials , Strengthen the quality supervision and management of the entire process of production and circulation of Chinese medicinal materials to ensure the quality and safety of Chinese medicinal materials. It 22 The state encourages the development of Chinese medicinal materials to standardize planting and breeding, strictly manage the use of agricultural input products such as pesticides, fertilizers, and prohibit the use of toxic and highly toxic pesticides during the planting of Chinese medicinal materials. , Improve the quality of Chinese medicinal materials. It 23 The state establishes the evaluation system of Chinese medicinal materials to support the selection of Chinese medicinal materials, support the construction of the production base of Chinese medicinal materials, strengthen the ecological environmental protection of the production base of Chinese medicinal materials, and encourage geographical geography to adopt geography Measures and other measures to protect the Chinese medicinal materials. The Chinese medicinal materials described in the previous paragraph refer to the preferably selected by the long -term application of Chinese medicine and produced in specific regions. Compared with the same type of Chinese medicinal materials produced in other regions, the quality and efficacy are better, and the quality is stable. It has a high reputation. Chinese medicinal materials. It 24 The Drug Supervision and Administration Department of the State Council shall organize and strengthen the monitoring of the quality of Chinese medicinal materials, and regularly announce the monitoring results to the society on a regular basis. Relevant departments of the State Council shall assist in the work related to monitoring the quality of Chinese medicinal materials. Collecting and storing Chinese medicinal materials and preliminary processing of Chinese medicinal materials shall meet the relevant national technical specifications, standards and management regulations. The state encourages the development of modern circulation systems for Chinese medicinal materials, improves the technical levels of Chinese medicinal materials packaging, warehousing and other technical levels, and establishes the traceability system for circulation of Chinese medicinal materials. Pharmaceutical manufacturers should establish a purchase inspection record system when purchasing Chinese medicinal materials. Chinese medicinal materials operators shall establish a purchase inspection and purchase and sales record system, and indicate the origin of Chinese medicinal materials. 25. The state’s protection of wild animal and plant resources for the protection of pharmaceuticals, and a dynamic monitoring and regular census of medicinal wild animals and plant resources, establishing medicinal wild animals and plant resource genetic libraries, and encouraging the development of artificial planting and breeding. Support the protection, breeding and related research of precious and endangered medicine for wild and plant in accordance with the law. It 26 TCM doctors who practice in village medical institutions, and rural doctors with the knowledge and recognition ability of traditional Chinese medicinal materials may be used in accordance with relevant national regulations, self -collection of real estate Chinese medicinal materials and in their practice activities.
The main policies of the reform of the drug production and circulation system: 1. Increase the adjustment of the drug production structure strictly, strictly enter the access conditions of drug production enterprises, control the capacity of new production and processing, and stop low -level repetitive construction. In the future, pharmaceutical manufacturers must gradually reach the “Quality Management Specifications for Drug Production Enterprises” (GMP). Encourage drug manufacturers to increase technology investment and develop new products and special products. 2. Accelerate the reform of the property rights system of pharmaceutical manufacturers and encourage various industries and various economic components to participate in various methods such as mergers, reorganization, and union. Actively cultivate and develop diversified investment entities, promote pharmaceutical distribution enterprises to enhance market competitiveness to improve the economic benefits of enterprises, in accordance with the principles of equality, mutual benefit and complementary advantages, use enterprises as the main body and capital as the link. Through the market, a group of group companies cross -regional, cross -industry, cross -ownership and multinational operations are formed. 3. Promote the reform of drug circulation order and advocate that pharmaceutical wholesale enterprises implement proxy distribution systems. Allows and encourages conditional wholesale enterprises to merge across regions or unite cities and county -level wholesale enterprises to reorganize the city and county -level wholesale enterprises into regional grassroots distribution centers to implement unified purchase, unified marketing strategies, unified accounting, and approval of zero integrity , Form a large -scale advantage operation and change the situation of decentralized operations within the enterprise. In order to reduce costs, improve benefits, and provide high -quality, convenient and fast services. Advocating pharmaceutical retail enterprises to implement chain operations. Under the principle of adhering to the “reasonable layout and facilitating the masses”, the implementation of the central city pharmaceutical retail enterprises to take a chain road and actively develop community pharmacies, and promote the centralization of pharmaceutical retail. Pharmaceutical retail chain enterprises implement six unifications of purchase, storage, transportation, price, corporate image, internal management and economic accounting to increase benefits, reduce costs, reduce prices, and benefit the country and the people. Implement bidding and procurement of drugs of medical institutions. In order to regulate the drug purchase and sales activities of medical institutions, increase the transparency of drug procurement, curb the inappropriate winds in the field of drug circulation, reduce the burden of social medical expenses, and ensure the smooth implementation of the basic medical insurance system of urban employees, and medical institutions in counties and counties above the counties And the drugs with a large number of clinical use of centralized bidding and procurement.
Legal basis:
“The Law of the Chinese Medicine of the People’s Republic of China”
The national medicines formulated, collected, storage, and initial processing of traditional Chinese pharmaceutical materials , Strengthen the quality supervision and management of the entire process of production and circulation of Chinese medicinal materials to ensure the quality and safety of Chinese medicinal materials.
It 22 The state encourages the development of Chinese medicinal materials to standardize planting and breeding, strictly manage the use of agricultural input products such as pesticides, fertilizers, and prohibit the use of toxic and highly toxic pesticides during the planting of Chinese medicinal materials. , Improve the quality of Chinese medicinal materials.
It 23 The state establishes the evaluation system of Chinese medicinal materials to support the selection of Chinese medicinal materials, support the construction of the production base of Chinese medicinal materials, strengthen the ecological environmental protection of the production base of Chinese medicinal materials, and encourage geographical geography to adopt geography Measures and other measures to protect the Chinese medicinal materials. The Chinese medicinal materials described in the previous paragraph refer to the preferably selected by the long -term application of Chinese medicine and produced in specific regions. Compared with the same type of Chinese medicinal materials produced in other regions, the quality and efficacy are better, and the quality is stable. It has a high reputation. Chinese medicinal materials.
It 24 The Drug Supervision and Administration Department of the State Council shall organize and strengthen the monitoring of the quality of Chinese medicinal materials, and regularly announce the monitoring results to the society on a regular basis. Relevant departments of the State Council shall assist in the work related to monitoring the quality of Chinese medicinal materials. Collecting and storing Chinese medicinal materials and preliminary processing of Chinese medicinal materials shall meet the relevant national technical specifications, standards and management regulations. The state encourages the development of modern circulation systems for Chinese medicinal materials, improves the technical levels of Chinese medicinal materials packaging, warehousing and other technical levels, and establishes the traceability system for circulation of Chinese medicinal materials. Pharmaceutical manufacturers should establish a purchase inspection record system when purchasing Chinese medicinal materials. Chinese medicinal materials operators shall establish a purchase inspection and purchase and sales record system, and indicate the origin of Chinese medicinal materials.
25. The state’s protection of wild animal and plant resources for the protection of pharmaceuticals, and a dynamic monitoring and regular census of medicinal wild animals and plant resources, establishing medicinal wild animals and plant resource genetic libraries, and encouraging the development of artificial planting and breeding. Support the protection, breeding and related research of precious and endangered medicine for wild and plant in accordance with the law.
It 26 TCM doctors who practice in village medical institutions, and rural doctors with the knowledge and recognition ability of traditional Chinese medicinal materials may be used in accordance with relevant national regulations, self -collection of real estate Chinese medicinal materials and in their practice activities.